Table 3. Prevalence/confidence interval of metabolic syndrome components in Brazilian adolescents.
Study | Prevalence (%) or 95%CI* of MS components | Nutritional status (%) | ||||
---|---|---|---|---|---|---|
AO | High BP | HG | Low HDL-C | HTG | ||
Quintão et al. 17 | 1.4 (males) 4.0 (females) |
16.7 (males) 3.0 (females) |
0 (males) 1.0 (females) |
30.6 (males) 35.0 (females) |
0 (males) 4.0 (females) |
OW: 11.6 OB: 2.9 |
Alvarez et al. 18 | 9.0 (6.30–12.90) |
12.5 (7.90–17.05) |
22.3 (13.30–31.70) |
32.5 (23.60–41.40) |
3.7 (1.90–5.40) |
OW–OB: 15.8 |
Stabelini Neto et al. 19 | Not informed | 18.9 | 4.7 | 29.2 | 18.3 | LW: 5.2 ET: 77.8 OW: 11.0 OB: 6.0 |
de Sousa et al. 20 | 46.8 | 18.4 | 16.0 | 54.0 | 27.6 | Not informed |
Furtado Neto e Ribeiro 21 | 12.2 | 12.2 | 0.40 | 37.4 | 17.7 | LW: 30.3 ET: 33.1 OW: 11.1 OB: 25.4 |
Granjeiro et al. 22 | 2.0 (0.64–4.70) |
12.9 (8.76–18.03) |
4.5 (2.19–8.07) |
23.3 (17.83–29.47); |
6.9 (3.99–11.09) |
OW–OB: 14.4 |
Kuschnir et al. 23 | 12.6 (11.60–13.70) |
8.2 (7.60–8.90) |
4.1 (3.50–4.80) |
32.7 (30.30–35.20) |
4.6 (4.10–5.10) |
Not informed |
Assis et al. 24 | 19.9 (15.52–24.82) |
7.6 (4.89–11.21) |
2.9 (1.37–5.58) |
23.5 (18.84–28.70) |
8.0 (5.16–11.59) |
OB: 27.5 |
Pani et al. 25 | 11.3 | 1.9 | 7.5 | 22.6 | 20.7 | OW: 17.0 OB: 7.5 |
dos Santos et al. 26 | 15.3 | 8.8 | 5.1 | 25.2 | 6.6 | LW: 6.6 ET: 67.5 OW:15.3 OB: 10.6 |
Reuter et al. 28 | 7.6 | 18.7 | 14.1 | 3.3 | 4.7 | LW–ET: 72.2 OW: 16.6 OB: 11.2 |
Guilherme et al. 29 | Not informed | 15.4 | 12.4 | Not informed | Not informed | Not informed |
Lustosa et al. 30 | 11.9 | 5.2 | 18.6 | 50.5 | 4.3 | LW: 2.5 ET: 80.7 OW: 12.5 OB: 4.3 |
Some studies showed the prevalence of components MS, whereas others showed the prevalence and confidence interval for those components. MS: metabolic syndrome; 95%CI: confidence interval; AO: abdominal obesity; BP: blood pressure; HG: hyperglycemia; HDL-C: high-density lipoprotein cholesterol; HTG: high serum triglyceride; OW: overweight; OB: obesity; LW: low weight; ET: eutrophy.